Global Center for Medical Innovation

Successfully Guiding Medtech Innovation - GCMI Atlanta

Leading minds in global health understand the magnitude of the impact our work can, accomplish. This would not be possible without GCMI.”

Steven Damon, CEO, Micron Biomedical
Click Here

The earlier you reach out to GCMI for guidance, the easier your journey is going to be.

Jud Ready, PhD, CEO, HubHygiene
Click Here

We can’t get where we want to go, as efficiently and effectively as we need to get there without GCMI.

Kamil Makhnejia, Chief Operating Officer & VP, Clinical Development, Jackson Medical
Click Here

The GCMI team always delivered. Their sensitivity to time and budget allowed us to take our device from ideation to FDA submission in 10 months.

Lou Malice, CEO, NFANT Labs
Click Here

By the time we entered ZeroTo510, we had gained a significant amount of confidence in the unmet need, the technology and the medtech-based business we are building

Stephen Kalinsky, Co-Founder & CTO, Augment Health
Click Here

Our journey toward commercialization of our new technology would have taken years longer without GCMI’s Phase Zero and Phase One services.

Josh Lee, Co-Founder & CEO, WisMedical
Click Here

Experienced staff is one of the most important things. They listen and collaborate. ‘Easy to work with’ is a great strength the GCMI staff possesses.

Omer Inan, PhD, Associate Professor of Electrical and Computer Engineering and Adjunct Associate Professor of Biomedical Engineering, Georgia Tech
Click Here

Our Mission

Our mission at GCMI Atlanta, a Georgia Tech affiliate, is to help direct the development, testing, and commercialization of innovative medical products that improve quality based outcomes and delivery of healthcare for patients.

ISO13485 and 21CFR820 compliant processes

Manufacturer of record for clinical studies

Integral to the Georgia Tech innovation ecosystem

Get in touch
View Projects

Capital-efficient Phased Approach

Expertise in all relevant subject matter

Deep experience supporting innovators and startups

ISO13485-Compliant QMS

GCMI Atlanta - Services

We provide a full range of medical device development services

Prototyping

Market Assessment

Usability & Human Factors

Risk Analysis

Design History File Creation

Verification & Validation Testing

Professor Omer Inan
Omer Inan
Professor and Department Chair, Georgia Tech - ECE
"Don’t be afraid to engage the GCMI team early in the thought process and leverage their experience. They can really be helpful in putting the product development and commercialization structure around a broad range of medical technologies.”

Have an idea? Let's discuss it!

Contact us now
GCMI Interim Executive Director, Saylan Lukas

Saylan Lukas

Interim Executive Director

“I always enjoy getting the opportunity to go to surgery and see the products that I have worked on actually be used to positively impact patient’s lives.

Medical device product development is such rewarding work since we get to easily see a direct impact that the hard work produces.”

Medical Device Development Process

Phase 0

Feasibility

In this pre-QMS phase, all the messy details are worked out and de-risked. This is critical to ensure that not only can a device safely and legally be brought to market, but that the market and business strategy will support its adoption.
Phase 1

Concept

In the first Design Controls phase, plans for regulatory compliance, testing, manufacturing, and risk management are established. A Design History File begins here.​

Phase 2

Design & Development

In this phase, the design is frozen to allow the commencement of test article production required in later stages. All known risks must be addressed to avoid wasted time and capital in the later stages, which become increasingly costly.
Phase 3

Verification

In this stage, testing is performed on clinically-equivalent devices produced in an ISO13485 Quality Management System. Tests such as transit simulation, mechanical testing, and accelerated aging may be performed.
Phase 4

Validation

In this stage, the real test of the clinical value of the device is examined by assessing its effectiveness in the actual intended contexts of use.
Phase 5

Manufacturing Transfer

In this stage, the device has been de-risked and there is high assurance of its regulatory approval. Supply chain, logistics, and sales operations will be spooled up to coincide with regulatory and IP milestones to ensure a successful and profitable launch.

GCMI Atlanta - 575 14th Street, Suite 100, Atlanta, Georgia, 30318

Please call before visiting

info@devices.net

For email inquiries